The risk or severity of adverse effects can be increased when Lofexidine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Droxicam is combined with equilin.


The risk or severity of adverse effects can be increased when HEROIN is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when olanzapine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when tolterodine is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when olanzapine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when quazepam is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when docetaxel is combined with Raltitrexed.


The risk or severity of adverse effects can be increased when protriptyline is combined with doxepin.


The risk or severity of adverse effects can be increased when docetaxel is combined with chlorambucil.


The risk or severity of adverse effects can be increased when docetaxel is combined with bleomycin.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with brotizolam.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when nystatin is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Olsalazine.


The risk or severity of adverse effects can be increased when oxymetazoline is combined with dopamine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with ibuprofen.


The risk or severity of adverse effects can be increased when oxycodone is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when oxycodone is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when butamben is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with Gemifloxacin.


The risk or severity of adverse effects can be increased when Lofexidine is combined with Methylnaltrexone.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when pramipexole is combined with diltiazem.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when butorphanol is combined with moclobemide.


The risk or severity of adverse effects can be increased when carprofen is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when oxycodone is combined with risperidone.


The risk or severity of adverse effects can be increased when butorphanol is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when methoxamine is combined with acebutolol.


The risk or severity of adverse effects can be increased when butorphanol is combined with chlormezanone.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when carprofen is combined with amcinonide.


The risk or severity of adverse effects can be increased when betamethasone is combined with donepezil.


The risk or severity of adverse effects can be increased when imipramine is combined with minoxidil.


The risk or severity of adverse effects can be increased when LISURIDE is combined with clotiazepam.


The risk or severity of adverse effects can be increased when Flupentixol is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when butorphanol is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when butorphanol is combined with bumetanide.


The risk or severity of adverse effects can be increased when ILOPROST is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when cilnidipine is combined with propranolol.


The risk or severity of adverse effects can be increased when Apremilast is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when cilnidipine is combined with clonidine.


The risk or severity of adverse effects can be increased when tetracaine is combined with promethazine.


The risk or severity of adverse effects can be increased when thalidomide is combined with nisoldipine.


The risk or severity of adverse effects can be increased when lorazepam is combined with thiopental.


The risk or severity of adverse effects can be increased when fluocinonide is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when mesoridazine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when isoflurane is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Tixocortol.


The risk or severity of adverse effects can be increased when fenoldopam is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when reserpine is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when dibucaine is combined with clomipramine.


The risk or severity of adverse effects can be increased when METYROSINE is combined with paroxetine.


The risk or severity of adverse effects can be increased when docetaxel is combined with Trifluridine.


The risk or severity of adverse effects can be increased when amifostine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with Tapentadol.


The risk or severity of adverse effects can be increased when nimesulide is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when amitriptyline is combined with Milnacipran.


The risk or severity of adverse effects can be increased when nimesulide is combined with formestane.


The risk or severity of adverse effects can be increased when anastrozole is combined with atorvastatin.


The risk or severity of adverse effects can be increased when fludiazepam is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Nabilone is combined with tolazoline.


The risk or severity of adverse effects can be increased when aspirin is combined with methazolamide.


The risk or severity of adverse effects can be increased when imipramine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Nabilone is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with ouabain.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Panobinostat.


The risk or severity of adverse effects can be increased when DEFLAZACORT is combined with enoxacin.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with amisulpride.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when loxapine is combined with doxepin.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when dipyridamole is combined with papaverine.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with acetylcholine.


The risk or severity of adverse effects can be increased when butorphanol is combined with enflurane.


The risk or severity of adverse effects can be increased when acemetacin is combined with desoximetasone.


The risk or severity of adverse effects can be increased when meperidine is combined with Perospirone.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with chloroquine.


The risk or severity of adverse effects can be increased when tolmetin is combined with resveratrol.


The risk or severity of adverse effects can be increased when Naftifine is combined with paramethasone.


The risk or severity of adverse effects can be increased when perphenazine is combined with thiopental.


The risk or severity of adverse effects can be increased when azelastine is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when difluprednate is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when Vilazodone is combined with reserpine.


The risk or severity of adverse effects can be increased when carvedilol is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with sulindac.


The risk or severity of adverse effects can be increased when imipramine is combined with Salbutamol.


The risk or severity of adverse effects can be increased when Eletriptan is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when tolmetin is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when betaxolol is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when dipyridamole is combined with nifedipine.


The risk or severity of adverse effects can be increased when tolmetin is combined with fenbufen.


The risk or severity of adverse effects can be increased when protriptyline is combined with trimipramine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when Nabilone is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Sacubitril is combined with resveratrol.


The risk or severity of adverse effects can be increased when DIMENHYDRINATE is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when halothane is combined with Pizotifen.


The risk or severity of adverse effects can be increased when prazepam is combined with Retigabine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Metipranolol.


The risk or severity of adverse effects can be increased when dyclonine is combined with mesoridazine.


The risk or severity of adverse effects can be increased when dyclonine is combined with maprotiline.


The risk or severity of adverse effects can be increased when resveratrol is combined with flumethasone.


The risk or severity of adverse effects can be increased when bromazepam is combined with clomipramine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when docetaxel is combined with Romidepsin.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Tavaborole is combined with isradipine.


The risk or severity of adverse effects can be increased when estazolam is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when valsartan is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when trimetrexate is combined with cinnarizine.


The risk or severity of adverse effects can be increased when dyclonine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when buspirone is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when sevoflurane is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when sevoflurane is combined with irbesartan.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when lisinopril is combined with bumetanide.


The risk or severity of adverse effects can be increased when sevoflurane is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when lisinopril is combined with quinapril.


The risk or severity of adverse effects can be increased when Tianeptine is combined with ritodrine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with felodipine.


The risk or severity of adverse effects can be increased when diflorasone is combined with mefloquine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with zotepine.


The risk or severity of adverse effects can be increased when nilvadipine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when vinorelbine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Rotigotine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with amprenavir.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Eplerenone.


The risk or severity of adverse effects can be increased when bromocriptine is combined with methazolamide.


The risk or severity of adverse effects can be increased when Olmesartan is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with Cis-mdp.


The risk or severity of adverse effects can be increased when bromocriptine is combined with TAMSULOSIN.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when isradipine is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when flunisolide is combined with decamethonium.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Olmesartan.


The risk or severity of adverse effects can be increased when zotepine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when apraclonidine is combined with Riociguat.


The risk or severity of adverse effects can be increased when altretamine is combined with leflunomide.


The risk or severity of adverse effects can be increased when irbesartan is combined with papaverine.


The risk or severity of adverse effects can be increased when secobarbital is combined with procaine.


The risk or severity of adverse effects can be increased when olanzapine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when clozapine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when zaleplon is combined with sulpiride.


The risk or severity of adverse effects can be increased when chlorthalidone is combined with timolol.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with acetazolamide.


The risk or severity of adverse effects can be increased when zaleplon is combined with carisoprodol.


The risk or severity of adverse effects can be increased when atenolol is combined with Eprosartan.


The risk or severity of adverse effects can be increased when floctafenine is combined with Deferasirox.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with Clevidipine.


The risk or severity of adverse effects can be increased when sulindac is combined with budesonide.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Normethadone.


The risk or severity of adverse effects can be increased when floctafenine is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when THYMOL is combined with flunarizine.


The risk or severity of adverse effects can be increased when salicylamide is combined with medrysone.


The risk or severity of adverse effects can be increased when HEROIN is combined with Flibanserin.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when dicyclomine is combined with hydromorphone.


The risk or severity of adverse effects can be increased when dantrolene is combined with Flibanserin.


The risk or severity of adverse effects can be increased when norepinephrine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when sevoflurane is combined with propoxyphene.


The risk or severity of adverse effects can be increased when sevoflurane is combined with dyclonine.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with paroxetine.


The risk or severity of adverse effects can be increased when ipratropium is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when azelastine is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when Droxicam is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when Fluticasone furoate is combined with edrophonium.


The risk or severity of adverse effects can be increased when fenbufen is combined with Tixocortol.


The risk or severity of adverse effects can be increased when azelastine is combined with amcinonide.


The risk or severity of adverse effects can be increased when meprobamate is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when enalapril is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when milrinone is combined with salicylic acid.


The risk or severity of adverse effects can be increased when perphenazine is combined with tetracaine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with propofol.


The risk or severity of adverse effects can be increased when tizanidine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when baclofen is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with flunarizine.


The risk or severity of adverse effects can be increased when sulpiride is combined with topiramate.


The risk or severity of adverse effects can be increased when zaleplon is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with cetirizine.


The risk or severity of adverse effects can be increased when flurazepam is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with maprotiline.


The risk or severity of adverse effects can be increased when bupivacaine is combined with selegiline.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Perospirone.


The risk or severity of adverse effects can be increased when proparacaine is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with papaverine.


The risk or severity of adverse effects can be increased when minoxidil is combined with furosemide.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with nifedipine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with tetracaine.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with MELPERONE.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with zotepine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Levalbuterol.


The risk or severity of adverse effects can be increased when carisoprodol is combined with Olopatadine.


The risk or severity of adverse effects can be increased when sulindac is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when triprolidine is combined with tiagabine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with efavirenz.


The risk or severity of adverse effects can be increased when triprolidine is combined with trimipramine.


The risk or severity of adverse effects can be increased when isoflurane is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when metolazone is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Pipamperone.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with niflumic acid.


The risk or severity of adverse effects can be increased when loxapine is combined with topiramate.


The risk or severity of adverse effects can be increased when butalbital is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when oxiconazole is combined with Pinaverium.


The risk or severity of adverse effects can be increased when pentobarbital is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when pentobarbital is combined with fludiazepam.


The risk or severity of adverse effects can be increased when Telaprevir is combined with toremifene.


The risk or severity of adverse effects can be increased when halothane is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with sulpiride.


The risk or severity of adverse effects can be increased when butorphanol is combined with furosemide.


The risk or severity of adverse effects can be increased when Telaprevir is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when triazolam is combined with dyclonine.


The risk or severity of adverse effects can be increased when triazolam is combined with propoxyphene.


The risk or severity of adverse effects can be increased when moclobemide is combined with dipivefrin.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Agomelatine is combined with felbamate.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Linagliptin.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when floctafenine is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when amoxapine is combined with Frovatriptan.


The risk or severity of adverse effects can be increased when isoflurane is combined with carisoprodol.


The risk or severity of adverse effects can be increased when isoflurane is combined with sulpiride.


The risk or severity of adverse effects can be increased when isoflurane is combined with nimodipine.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when salicylamide is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when Dexmethylphenidate is combined with amitriptyline.


The risk or severity of adverse effects can be increased when Clobetasone is combined with Demecarium.


The risk or severity of adverse effects can be increased when butalbital is combined with Retigabine.


The risk or severity of adverse effects can be increased when ketamine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Tixocortol is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when flurazepam is combined with scopolamine.


The risk or severity of adverse effects can be increased when Tixocortol is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when quinapril is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when lidocaine is combined with glutethimide.


The risk or severity of adverse effects can be increased when mesoridazine is combined with efavirenz.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with indapamide.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Etomidate is combined with clonidine.


The risk or severity of adverse effects can be increased when phentolamine is combined with tizanidine.


The risk or severity of adverse effects can be increased when codeine is combined with secobarbital.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with mesoridazine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Perospirone.


The risk or severity of adverse effects can be increased when Almotriptan is combined with Lorcaserin.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when chloroquine is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when ropinirole is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Remoxipride.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when clomipramine is combined with Salbutamol.


The risk or severity of adverse effects can be increased when Masoprocol is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with sulpiride.


The risk or severity of adverse effects can be increased when dyclonine is combined with tizanidine.


The risk or severity of adverse effects can be increased when loxapine is combined with oxycodone.


The risk or severity of adverse effects can be increased when Masoprocol is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with DESONIDE.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when midazolam is combined with topiramate.


The risk or severity of adverse effects can be increased when etodolac is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when nilvadipine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when Escitalopram is combined with quetiapine.


The risk or severity of adverse effects can be increased when atorvastatin is combined with cimetidine.


The risk or severity of adverse effects can be increased when oxycodone is combined with pimozide.


The risk or severity of adverse effects can be increased when pramipexole is combined with nicardipine.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when cilazapril is combined with meperidine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with sumatriptan.


The risk or severity of adverse effects can be increased when Caspofungin is combined with barnidipine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Nepafenac is combined with indomethacin.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with metolazone.


The risk or severity of adverse effects can be increased when butenafine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when dibucaine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with paramethasone.


The risk or severity of adverse effects can be increased when dibucaine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when clozapine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when Butethal is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Aliskiren.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when ondansetron is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when Tramadol is combined with olanzapine.


The risk or severity of adverse effects can be increased when apraclonidine is combined with Nebivolol.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with sertraline.


The risk or severity of adverse effects can be increased when ketorolac is combined with difluprednate.


The risk or severity of adverse effects can be increased when ketorolac is combined with halcinonide.


The risk or severity of adverse effects can be increased when daunorubicin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when benazepril is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when tenoxicam is combined with alclometasone.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with doxepin.


The risk or severity of adverse effects can be increased when floctafenine is combined with paramethasone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when floctafenine is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with betamethasone.


The risk or severity of adverse effects can be increased when betaxolol is combined with sotalol.


The risk or severity of adverse effects can be increased when betaxolol is combined with floctafenine.


The risk or severity of adverse effects can be increased when leflunomide is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with malathion.


The risk or severity of adverse effects can be increased when flunarizine is combined with simvastatin.


The risk or severity of adverse effects can be increased when fenoprofen is combined with Halobetasol.


The risk or severity of adverse effects can be increased when sulfadiazine is combined with methotrexate.


The risk or severity of adverse effects can be increased when lidocaine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when meprobamate is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with Pipamperone.


The risk or severity of adverse effects can be increased when cabergoline is combined with ambroxol.


The risk or severity of adverse effects can be increased when Fluprednidene is combined with fleroxacin.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when buspirone is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with BENDROFLUMETHIAZIDE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with metoclopramide.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with atenolol.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when ipratropium is combined with butorphanol.


The risk or severity of adverse effects can be increased when estazolam is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when quetiapine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when estazolam is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with haloperidol.


The risk or severity of adverse effects can be increased when tolmetin is combined with acemetacin.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with proparacaine.


The risk or severity of adverse effects can be increased when norepinephrine is combined with methoxamine.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Halazepam.


The risk or severity of adverse effects can be increased when alprazolam is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when clomipramine is combined with terbutaline.


The risk or severity of adverse effects can be increased when clorazepate is combined with tiagabine.


The risk or severity of adverse effects can be increased when NITROUS ACID is combined with brimonidine.


The risk or severity of adverse effects can be increased when loratadine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when clomipramine is combined with Eprosartan.


The risk or severity of adverse effects can be increased when alprazolam is combined with butalbital.


The risk or severity of adverse effects can be increased when MELPERONE is combined with meclizine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with brotizolam.


The risk or severity of adverse effects can be increased when Eprosartan is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when barnidipine is combined with diltiazem.


The risk or severity of adverse effects can be increased when loratadine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with valsartan.


The risk or severity of adverse effects can be increased when Toloxatone is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when isoflurane is combined with indapamide.


The risk or severity of adverse effects can be increased when isoflurane is combined with proparacaine.


The risk or severity of adverse effects can be increased when Sorafenib is combined with leflunomide.


The risk or severity of adverse effects can be increased when isoflurane is combined with Halazepam.


The risk or severity of adverse effects can be increased when isoflurane is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when nitric oxide is combined with ramipril.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Enasidenib.


The risk or severity of adverse effects can be increased when procarbazine is combined with Asenapine.


The risk or severity of adverse effects can be increased when oxycodone is combined with bumetanide.


The risk or severity of adverse effects can be increased when miconazole is combined with nisoldipine.


The risk or severity of adverse effects can be increased when perphenazine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when temazepam is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when anagrelide is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when pentobarbital is combined with scopolamine.


The risk or severity of adverse effects can be increased when docetaxel is combined with 4-PHENYLBUTYRIC ACID.


The risk or severity of adverse effects can be increased when Phenelzine is combined with PIRBUTEROL.


The risk or severity of adverse effects can be increased when docetaxel is combined with Pralatrexate.


The risk or severity of adverse effects can be increased when phenylephrine is combined with methoxamine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with hydralazine.


The risk or severity of adverse effects can be increased when gabapentin is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when moclobemide is combined with droxidopa.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Rotigotine is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when apomorphine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when apomorphine is combined with lisinopril.


The risk or severity of adverse effects can be increased when Rotigotine is combined with metolazone.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with proparacaine.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with Halazepam.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when sumatriptan is combined with risperidone.


The risk or severity of adverse effects can be increased when cilnidipine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when chlormezanone is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when amobarbital is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when quinapril is combined with suprofen.


The risk or severity of adverse effects can be increased when thiamylal is combined with Butethal.


The risk or severity of adverse effects can be increased when sotalol is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with tizanidine.


The risk or severity of adverse effects can be increased when thiamylal is combined with lithium ion.


The risk or severity of adverse effects can be increased when benztropine is combined with oxycodone.


The risk or severity of adverse effects can be increased when Melatonin is combined with Pramocaine.


The risk or severity of adverse effects can be increased when levorphanol is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when phenylephrine is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when zopiclone is combined with Articaine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with HEROIN.


The risk or severity of adverse effects can be increased when amobarbital is combined with sertraline.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with irbesartan.


The risk or severity of adverse effects can be increased when enflurane is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when alprazolam is combined with oxprenolol.


The risk or severity of adverse effects can be increased when fexofenadine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Tedizolid phosphate is combined with perphenazine.


The risk or severity of adverse effects can be increased when Agomelatine is combined with desipramine.


The risk or severity of adverse effects can be increased when enflurane is combined with Remoxipride.


The risk or severity of adverse effects can be increased when methysergide is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Lopinavir is combined with toremifene.


The risk or severity of adverse effects can be increased when methysergide is combined with Ticagrelor.


The risk or severity of adverse effects can be increased when methysergide is combined with tofisopam.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with maprotiline.


The risk or severity of adverse effects can be increased when methylene blue is combined with Arformoterol.


The risk or severity of adverse effects can be increased when Lopinavir is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when zopiclone is combined with flunarizine.


The risk or severity of adverse effects can be increased when procarbazine is combined with Levomepromazine.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when benzocaine is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when benzocaine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when amobarbital is combined with duloxetine.


The risk or severity of adverse effects can be increased when thioridazine is combined with ketamine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Desloratadine.


The risk or severity of adverse effects can be increased when amobarbital is combined with fluoxetine.


The risk or severity of adverse effects can be increased when butamben is combined with phenytoin.


The risk or severity of adverse effects can be increased when Flibanserin is combined with Iloperidone.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Perospirone.


The risk or severity of adverse effects can be increased when cetirizine is combined with nefazodone.


The risk or severity of adverse effects can be increased when oxprenolol is combined with acetylcholine.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Tolcapone.


The risk or severity of adverse effects can be increased when amobarbital is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Tolcapone is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Pipamperone.


The risk or severity of adverse effects can be increased when perphenazine is combined with levorphanol.


The risk or severity of adverse effects can be increased when pimozide is combined with oxprenolol.


The risk or severity of adverse effects can be increased when cetirizine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Cariprazine.


The risk or severity of adverse effects can be increased when trimipramine is combined with Salbutamol.


The risk or severity of adverse effects can be increased when methocarbamol is combined with flunarizine.


The risk or severity of adverse effects can be increased when diclofenac is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with desipramine.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with nimesulide.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with clonidine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with selegiline.


The risk or severity of adverse effects can be increased when meprobamate is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when nicergoline is combined with itraconazole.


The risk or severity of adverse effects can be increased when nicergoline is combined with cilostazol.


The risk or severity of adverse effects can be increased when Isavuconazole is combined with lovastatin.


The risk or severity of adverse effects can be increased when diclofenac is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with loratadine.


The risk or severity of adverse effects can be increased when clozapine is combined with selegiline.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with ethosuximide.


The risk or severity of adverse effects can be increased when prazosin is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with levodopa.


The risk or severity of adverse effects can be increased when gabapentin is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Rufinamide is combined with butamben.


The risk or severity of adverse effects can be increased when Escitalopram is combined with Asenapine.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with norfloxacin.


The risk or severity of adverse effects can be increased when olanzapine is combined with HEROIN.


The risk or severity of adverse effects can be increased when quazepam is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when reserpine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when reserpine is combined with loxapine.


The risk or severity of adverse effects can be increased when BECLOMETHASONE DIPROPIONATE is combined with Echothiophate.


The risk or severity of adverse effects can be increased when nitrendipine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when codeine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Fospropofol is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Articaine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with timolol.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when bupivacaine is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when Telmisartan is combined with dipyridamole.


The risk or severity of adverse effects can be increased when amitriptyline is combined with vigabatrin.


The risk or severity of adverse effects can be increased when gabapentin is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when clorazepate is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when FLUTICASONE PROPIONATE is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when methadone is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when alprazolam is combined with mesoridazine.


The risk or severity of adverse effects can be increased when reserpine is combined with Eszopiclone.


The risk or severity of adverse effects can be increased when tubocurarine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when procarbazine is combined with Bambuterol.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with desipramine.


The risk or severity of adverse effects can be increased when reserpine is combined with nisoldipine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with butalbital.


The risk or severity of adverse effects can be increased when pergolide is combined with antipyrine.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Fospropofol.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Flupentixol.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with METAXALONE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when quazepam is combined with Ramelteon.


The risk or severity of adverse effects can be increased when quazepam is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with zotepine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with amisulpride.


The risk or severity of adverse effects can be increased when pergolide is combined with modafinil.


The risk or severity of adverse effects can be increased when bupivacaine is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when chloral hydrate is combined with etizolam.


The risk or severity of adverse effects can be increased when pergolide is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Pipamperone.


The risk or severity of adverse effects can be increased when BOPINDOLOL is combined with Cevimeline.


The risk or severity of adverse effects can be increased when BOPINDOLOL is combined with nicotine.


The risk or severity of adverse effects can be increased when sulpiride is combined with meclizine.


The risk or severity of adverse effects can be increased when loratadine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when midodrine is combined with nylidrin.


The risk or severity of adverse effects can be increased when Tolcapone is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Tolcapone is combined with nadolol.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with diethylstilbestrol.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with sulfanilamide.


The risk or severity of adverse effects can be increased when zopiclone is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when terazosin is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with felbamate.


The risk or severity of adverse effects can be increased when alclometasone is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when halothane is combined with Normethadone.


The risk or severity of adverse effects can be increased when irbesartan is combined with cilazapril.


The risk or severity of adverse effects can be increased when propoxyphene is combined with butamben.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Almotriptan.


The risk or severity of adverse effects can be increased when Sacubitril is combined with nadolol.


The risk or severity of adverse effects can be increased when selegiline is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with atenolol.


The risk or severity of adverse effects can be increased when scopolamine is combined with doxepin.


The risk or severity of adverse effects can be increased when Propacetamol is combined with DESONIDE.


The risk or severity of adverse effects can be increased when fenoprofen is combined with NAPROXEN.


The risk or severity of adverse effects can be increased when halothane is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when midazolam is combined with risperidone.


The risk or severity of adverse effects can be increased when Eprosartan is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when midazolam is combined with meclizine.


The risk or severity of adverse effects can be increased when Perospirone is combined with Pizotifen.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with acemetacin.


The risk or severity of adverse effects can be increased when barnidipine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when quazepam is combined with oxprenolol.


The risk or severity of adverse effects can be increased when butabarbital is combined with procaine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with tiapride.


The risk or severity of adverse effects can be increased when quazepam is combined with prazepam.


The risk or severity of adverse effects can be increased when oxprenolol is combined with triprolidine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when oxprenolol is combined with methocarbamol.


The risk or severity of adverse effects can be increased when oxprenolol is combined with spironolactone.


The risk or severity of adverse effects can be increased when meclizine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when epirizole is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when isradipine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when captopril is combined with Nepafenac.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with brimonidine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with Nabilone.


The risk or severity of adverse effects can be increased when nicotinamide is combined with pravastatin.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with HYDROCODONE.


The risk or severity of adverse effects can be increased when fludiazepam is combined with zonisamide.


The risk or severity of adverse effects can be increased when midodrine is combined with METHAMPHETAMINE.


The risk or severity of adverse effects can be increased when Clofarabine is combined with sotalol.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when baclofen is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when flurazepam is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when meperidine is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with daunorubicin.


The risk or severity of adverse effects can be increased when amifostine is combined with bupivacaine.


The risk or severity of adverse effects can be increased when amifostine is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when biperiden is combined with hyoscyamine.


The risk or severity of adverse effects can be increased when risperidone is combined with Desloratadine.


The risk or severity of adverse effects can be increased when thalidomide is combined with lisinopril.


The risk or severity of adverse effects can be increased when lisinopril is combined with quetiapine.


The risk or severity of adverse effects can be increased when thalidomide is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when docetaxel is combined with leflunomide.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with floctafenine.


The risk or severity of adverse effects can be increased when methadone is combined with Potassium citrate.


The risk or severity of adverse effects can be increased when Apremilast is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Pramocaine.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with chlordiazepoxide.


The risk or severity of adverse effects can be increased when MELPERONE is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when pargyline is combined with Arformoterol.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with prilocaine.


The risk or severity of adverse effects can be increased when selegiline is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when buspirone is combined with oxycodone.


The risk or severity of adverse effects can be increased when levorphanol is combined with chlormezanone.


The risk or severity of adverse effects can be increased when ethotoin is combined with zonisamide.


The risk or severity of adverse effects can be increased when tinidazole is combined with disulfiram.


The risk or severity of adverse effects can be increased when tolmetin is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Tiotropium is combined with Tramadol.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with quetiapine.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with formestane.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Iloperidone.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Fulvestrant.


The risk or severity of adverse effects can be increased when fenoprofen is combined with antipyrine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when methocarbamol is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when methylergonovine is combined with resveratrol.


The risk or severity of adverse effects can be increased when mesalamine is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with penbutolol.


The risk or severity of adverse effects can be increased when methylergonovine is combined with nicotinamide.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with trandolapril.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with bumetanide.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Vorinostat.


The risk or severity of adverse effects can be increased when oxycodone is combined with trazodone.


The risk or severity of adverse effects can be increased when methylergonovine is combined with gemfibrozil.


The risk or severity of adverse effects can be increased when bromocriptine is combined with benazepril.


The risk or severity of adverse effects can be increased when bromocriptine is combined with vincristine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when biperiden is combined with Propiverine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with docetaxel.


The risk or severity of adverse effects can be increased when Tapentadol is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when Eprosartan is combined with Clevidipine.


The risk or severity of adverse effects can be increased when olanzapine is combined with butalbital.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with potassium ion.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with brotizolam.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when apomorphine is combined with halothane.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when zaleplon is combined with Etidocaine.


The risk or severity of adverse effects can be increased when minoxidil is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when ketoprofen is combined with Droxicam.


The risk or severity of adverse effects can be increased when difluprednate is combined with donepezil.


The risk or severity of adverse effects can be increased when bupivacaine is combined with triprolidine.


The risk or severity of adverse effects can be increased when atenolol is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Olopatadine.


The risk or severity of adverse effects can be increased when perphenazine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when triamcinolone is combined with physostigmine.


The risk or severity of adverse effects can be increased when Apremilast is combined with Mometasone.


The risk or severity of adverse effects can be increased when flurazepam is combined with bromazepam.


The risk or severity of adverse effects can be increased when olanzapine is combined with secobarbital.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with protriptyline.


The risk or severity of adverse effects can be increased when prilocaine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when triamcinolone is combined with rivastigmine.


The risk or severity of adverse effects can be increased when oxazepam is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when methysergide is combined with ambroxol.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Droxicam.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when reserpine is combined with Torasemide.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when nimodipine is combined with furosemide.


The risk or severity of adverse effects can be increased when salicylic acid is combined with haloperidol.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when hydroxyzine is combined with sertraline.


The risk or severity of adverse effects can be increased when diltiazem is combined with labetalol.


The risk or severity of adverse effects can be increased when dibucaine is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when flumethasone is combined with physostigmine.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with terazosin.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with venlafaxine.


The risk or severity of adverse effects can be increased when tetracaine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when suprofen is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with ibuprofen.


The risk or severity of adverse effects can be increased when nimodipine is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when suprofen is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when triamcinolone is combined with galanthamine.


The risk or severity of adverse effects can be increased when losartan is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Deferasirox.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with clidinium.


The risk or severity of adverse effects can be increased when alprazolam is combined with tetracaine.


The risk or severity of adverse effects can be increased when methysergide is combined with thiopental.


The risk or severity of adverse effects can be increased when thioridazine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when zaleplon is combined with amobarbital.


The risk or severity of adverse effects can be increased when methysergide is combined with gemfibrozil.


The risk or severity of adverse effects can be increased when zaleplon is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when zaleplon is combined with lithium ion.


The risk or severity of adverse effects can be increased when zaleplon is combined with etizolam.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when methysergide is combined with docetaxel.


The risk or severity of adverse effects can be increased when Spirapril is combined with ketoprofen.


The risk or severity of adverse effects can be increased when hydromorphone is combined with lithium ion.


The risk or severity of adverse effects can be increased when Clevidipine is combined with Riociguat.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Butethal.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Flibanserin.


The risk or severity of adverse effects can be increased when hydromorphone is combined with amobarbital.


The risk or severity of adverse effects can be increased when pentazocine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with carprofen.


The risk or severity of adverse effects can be increased when barnidipine is combined with nicardipine.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Butethal.


The risk or severity of adverse effects can be increased when bumetanide is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when nimodipine is combined with sotalol.


The risk or severity of adverse effects can be increased when minoxidil is combined with trandolapril.


The risk or severity of adverse effects can be increased when haloperidol is combined with Butethal.


The risk or severity of adverse effects can be increased when Dapagliflozin is combined with Aliskiren.


The risk or severity of adverse effects can be increased when haloperidol is combined with amobarbital.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with Topiroxostat.


The risk or severity of adverse effects can be increased when tiapride is combined with scopolamine.


The risk or severity of adverse effects can be increased when prazepam is combined with imipramine.


The risk or severity of adverse effects can be increased when metolazone is combined with Nebivolol.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with tiaprofenic acid.


The risk or severity of adverse effects can be increased when Etomidate is combined with butamben.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when reserpine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Nelarabine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with tamoxifen.


The risk or severity of adverse effects can be increased when lidocaine is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when metoprolol is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with clonidine.


The risk or severity of adverse effects can be increased when efavirenz is combined with doxepin.


The risk or severity of adverse effects can be increased when oxaprozin is combined with estrone.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when phentolamine is combined with furosemide.


The risk or severity of adverse effects can be increased when flurazepam is combined with triflupromazine.


The risk or severity of adverse effects can be increased when proparacaine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when METAXALONE is combined with flunarizine.


The risk or severity of adverse effects can be increased when METAXALONE is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with brotizolam.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when benztropine is combined with trihexyphenidyl.


The risk or severity of adverse effects can be increased when tacrolimus is combined with thiotepa.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with clidinium.


The risk or severity of adverse effects can be increased when diazepam is combined with oxymorphone.


The risk or severity of adverse effects can be increased when tioconazole is combined with barnidipine.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with Eplerenone.


The risk or severity of adverse effects can be increased when pargyline is combined with brimonidine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with perphenazine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when Dothiepin is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when antipyrine is combined with equilin.


The risk or severity of adverse effects can be increased when prazepam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when ethopropazine is combined with butorphanol.


The risk or severity of adverse effects can be increased when imipramine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when imipramine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when hydromorphone is combined with PAMABROM.


The risk or severity of adverse effects can be increased when nicardipine is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when PARALDEHYDE is combined with sertraline.


The risk or severity of adverse effects can be increased when morphine is combined with lidocaine.


The risk or severity of adverse effects can be increased when procaine is combined with HEROIN.


The risk or severity of adverse effects can be increased when imipramine is combined with methyldopa.


The risk or severity of adverse effects can be increased when oxycodone is combined with potassium ion.


The risk or severity of adverse effects can be increased when glutethimide is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Butethal is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when cabergoline is combined with zolmitriptan.


The risk or severity of adverse effects can be increased when cabergoline is combined with acetaminophen.


The risk or severity of adverse effects can be increased when phenylephrine is combined with metaproterenol.


The risk or severity of adverse effects can be increased when cabergoline is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when propantheline is combined with Metixene.


The risk or severity of adverse effects can be increased when diclofenac is combined with resveratrol.


The risk or severity of adverse effects can be increased when Paliperidone is combined with bromazepam.


The risk or severity of adverse effects can be increased when promazine is combined with zaleplon.


The risk or severity of adverse effects can be increased when zopiclone is combined with Normethadone.


The risk or severity of adverse effects can be increased when promazine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when morphine is combined with isoflurane.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when morphine is combined with tretinoin.


The risk or severity of adverse effects can be increased when morphine is combined with ethotoin.


The risk or severity of adverse effects can be increased when Olmesartan is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when mepivacaine is combined with amisulpride.


The risk or severity of adverse effects can be increased when lithium ion is combined with Normethadone.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with QUINETHAZONE.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with polythiazide.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with terazosin.


The risk or severity of adverse effects can be increased when Tapentadol is combined with Mersalyl.


The risk or severity of adverse effects can be increased when antipyrine is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when Dothiepin is combined with Salmeterol.


The risk or severity of adverse effects can be increased when cocaine is combined with tiagabine.


The risk or severity of adverse effects can be increased when ramipril is combined with atenolol.


The risk or severity of adverse effects can be increased when bepridil is combined with triamterene.


The risk or severity of adverse effects can be increased when D-mannitol is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when meclizine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when papaverine is combined with terazosin.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with Propacetamol.


The risk or severity of adverse effects can be increased when enalapril is combined with mecamylamine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Saxagliptin is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when ILOPROST is combined with Tolcapone.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with Tenofovir disoproxil.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when bupivacaine is combined with brotizolam.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when josamycin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when prilocaine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with Gatifloxacin.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with memantine.


The risk or severity of adverse effects can be increased when Aclidinium is combined with Normethadone.


The risk or severity of adverse effects can be increased when amoxapine is combined with ARBUTAMINE.


The risk or severity of adverse effects can be increased when niflumic acid is combined with Propacetamol.


The risk or severity of adverse effects can be increased when prilocaine is combined with amisulpride.


The risk or severity of adverse effects can be increased when Nabilone is combined with rasagiline.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when cyclosporin A is combined with bumetanide.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with felodipine.


The risk or severity of adverse effects can be increased when metoclopramide is combined with promethazine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when metoclopramide is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Clevidipine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when tetracaine is combined with zotepine.


The risk or severity of adverse effects can be increased when diltiazem is combined with nadolol.


The risk or severity of adverse effects can be increased when citalopram is combined with Tapentadol.


The risk or severity of adverse effects can be increased when Isoconazole is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Isoconazole is combined with PERHEXILINE.


The risk or severity of adverse effects can be increased when chlorpheniramine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when loxapine is combined with buspirone.


The risk or severity of adverse effects can be increased when Masoprocol is combined with chloroquine.


The risk or severity of adverse effects can be increased when Etidocaine is combined with butalbital.


The risk or severity of adverse effects can be increased when Masoprocol is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when risperidone is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when clonidine is combined with losartan.


The risk or severity of adverse effects can be increased when bromazepam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when loxapine is combined with diazepam.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with quetiapine.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with terazosin.


The risk or severity of adverse effects can be increased when Triflusal is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when zaleplon is combined with tiapride.


The risk or severity of adverse effects can be increased when Masoprocol is combined with ketoprofen.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with levodopa.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with Apremilast.


The risk or severity of adverse effects can be increased when trazodone is combined with selegiline.


The risk or severity of adverse effects can be increased when Bortezomib is combined with pramipexole.


The risk or severity of adverse effects can be increased when prazepam is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with Lofexidine.


The risk or severity of adverse effects can be increased when scopolamine is combined with clidinium.


The risk or severity of adverse effects can be increased when estazolam is combined with etizolam.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with dienestrol.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when bumetanide is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with Tramadol.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when phenylephrine is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when fludiazepam is combined with doxepin.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with cetirizine.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with clemastine.


The risk or severity of adverse effects can be increased when Naftifine is combined with diflorasone.


The risk or severity of adverse effects can be increased when dibucaine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Vilazodone is combined with rasagiline.


The risk or severity of adverse effects can be increased when fludiazepam is combined with nefazodone.


The risk or severity of adverse effects can be increased when desoximetasone is combined with donepezil.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with flurbiprofen.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when diclofenac is combined with budesonide.


The risk or severity of adverse effects can be increased when sulconazole is combined with Pinaverium.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when LISURIDE is combined with chloramphenicol.


The risk or severity of adverse effects can be increased when cilnidipine is combined with lisinopril.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Tixocortol.


The risk or severity of adverse effects can be increased when cilnidipine is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when propofol is combined with promethazine.


The risk or severity of adverse effects can be increased when propofol is combined with clonazepam.


The risk or severity of adverse effects can be increased when ondansetron is combined with efavirenz.


The risk or severity of adverse effects can be increased when Pramocaine is combined with scopolamine.


The risk or severity of adverse effects can be increased when propranolol is combined with hydralazine.


The risk or severity of adverse effects can be increased when propranolol is combined with Varenicline.


The risk or severity of adverse effects can be increased when apomorphine is combined with metolazone.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when zaleplon is combined with scopolamine.


The risk or severity of adverse effects can be increased when dicyclomine is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Pramocaine.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with felbamate.


The risk or severity of adverse effects can be increased when apomorphine is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when fluoxetine is combined with zotepine.


The risk or severity of adverse effects can be increased when fluoxetine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when nisoldipine is combined with mecamylamine.


The risk or severity of adverse effects can be increased when tropicamide is combined with codeine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when chlorothiazide is combined with quetiapine.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when Nabilone is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when amoxapine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with furosemide.


The risk or severity of adverse effects can be increased when AMILORIDE is combined with tizanidine.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when secobarbital is combined with midazolam.


The risk or severity of adverse effects can be increased when Pipamperone is combined with valsartan.


The risk or severity of adverse effects can be increased when Pipamperone is combined with ramipril.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when hydromorphone is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Apremilast.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with HEROIN.


The risk or severity of adverse effects can be increased when codeine is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when hydromorphone is combined with butalbital.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Normethadone.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when apraclonidine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Paliperidone.


The risk or severity of adverse effects can be increased when oxymorphone is combined with thiopental.


The risk or severity of adverse effects can be increased when oxymorphone is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when oxymorphone is combined with ethosuximide.


The risk or severity of adverse effects can be increased when hydromorphone is combined with ondansetron.


The risk or severity of adverse effects can be increased when thiamylal is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Asenapine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when apraclonidine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when promazine is combined with triprolidine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Lurasidone.


The risk or severity of adverse effects can be increased when promazine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when promazine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when pentazocine is combined with desipramine.


The risk or severity of adverse effects can be increased when pentazocine is combined with thiamylal.


The risk or severity of adverse effects can be increased when benzocaine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when methoxamine is combined with PSEUDOEPHEDRINE.


The risk or severity of adverse effects can be increased when ipratropium is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when amoxapine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with tiapride.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when Eplerenone is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Pentolinium is combined with codeine.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when bromazepam is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with GALLAMINE TRIETHIODIDE.


The risk or severity of adverse effects can be increased when secobarbital is combined with benzocaine.


The risk or severity of adverse effects can be increased when Pregabalin is combined with MAGNESIUM OXIDE.


The risk or severity of adverse effects can be increased when bromazepam is combined with HEROIN.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when Ramelteon is combined with dantrolene.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with alclometasone.


The risk or severity of adverse effects can be increased when trimipramine is combined with Cariprazine.


The risk or severity of adverse effects can be increased when loxapine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when MELPERONE is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when azathioprine is combined with leflunomide.


The risk or severity of adverse effects can be increased when loxapine is combined with clonazepam.


The risk or severity of adverse effects can be increased when clorazepate is combined with citalopram.


The risk or severity of adverse effects can be increased when benazepril is combined with nimesulide.


The risk or severity of adverse effects can be increased when loxapine is combined with Melatonin.


The risk or severity of adverse effects can be increased when haloperidol is combined with meclizine.


The risk or severity of adverse effects can be increased when butenafine is combined with manidipine.


The risk or severity of adverse effects can be increased when brotizolam is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Lacidipine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when chloroquine is combined with estrone.


The risk or severity of adverse effects can be increased when enalapril is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when oxazepam is combined with nortriptyline.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with Flibanserin.


The risk or severity of adverse effects can be increased when brotizolam is combined with Levomilnacipran.